ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 143 filers reported holding ENDOCYTE INC in Q3 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $387,417 | -99.9% | 21,814 | 0.0% | 0.01% | +40.0% |
| Q2 2018 | $301,034,000 | +224552.2% | 21,814 | -25.7% | 0.01% | +400.0% |
| Q3 2015 | $134,000 | -36.2% | 29,340 | -12.4% | 0.00% | -50.0% |
| Q1 2015 | $210,000 | 0.0% | 33,505 | +0.5% | 0.00% | +100.0% |
| Q4 2014 | $210,000 | +3.4% | 33,337 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $203,000 | -7.7% | 33,337 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $220,000 | -64.7% | 33,337 | +27.2% | 0.00% | -50.0% |
| Q1 2014 | $624,000 | +122.9% | 26,208 | 0.0% | 0.00% | +100.0% |
| Q4 2013 | $280,000 | -19.8% | 26,208 | 0.0% | 0.00% | -33.3% |
| Q3 2013 | $349,000 | +1.5% | 26,208 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $344,000 | – | 26,208 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,364,648 | $14,401,000 | 1.20% |
| Asymmetry Capital Management, L.P. | 81,484 | $349,000 | 0.47% |
| PFM Health Sciences, LP | 3,441,594 | $14,730,000 | 0.35% |
| Perceptive Advisors | 1,451,700 | $6,213,000 | 0.21% |
| Leisure Capital Management | 28,304 | $121,000 | 0.10% |
| Cribstone Capital Management, LLC | 47,349 | $203,000 | 0.10% |
| EAM Investors, LLC | 98,034 | $420,000 | 0.08% |
| SG3 Management, LLC | 32,500 | $139,000 | 0.05% |
| Baker Brothers Advisors | 1,087,323 | $4,654,000 | 0.04% |
| Alpine Global Management, LLC | 33,675 | $144,000 | 0.03% |